This translational retrospective provides novel insight into sex hormone-mediated control of TMPRSS2 in the heart and coronary vasculature in a context of existing metabolic syndrome and cardiovascular disease, suggesting further scrutiny of sex and gene-based differences is warranted. This evidence concerns the gene TMPRSS2 and cardiovascular disorder.